
Outdated Genetic Tests May Leave Thousands of Women Unaware of Cancer Risks
Women who tested negative for cancer-related gene mutations in the 1990s and 2000s are now advised to retest due to significant advancements in genetic screening technology. Early tests focused only on BRCA1 and BRCA2 genes, but modern panels analyze dozens of additional genes linked to breast and ovarian cancer. A 2023 study found that 17.3% of individuals who initially tested negative were found to have a variant upon retesting. Experts warn that many patients remain unaware of this need, potentially delaying preventive measures. While barriers like cost and limited insurance coverage exist, retesting provides critical data for risk management and future medical decisions.












